Clinical Trial Update: Immunologic Memory (Supp. of ATN 024) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update on immunologic memory related to ATN 024 for HIV infections; the study status is COMPLETED.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infections

Snippet

Sponsor: University of North Carolina, Chapel Hill | Conditions: HIV Infections | Phase 4 | Status: COMPLETED